GMRx2 ACT1 UK update
TOPSPIN trial presented at AHA 2024
First Site Initiated for GMRx2 ACT
ICTU Global Launch
UNEEG Medical Hyposafe System – An Exploratory Feasibility Study
COVID-19 vaccination cuts infection risk by half in school-aged children - REACT
GMRx2 Placebo Controlled Trial (PCT)
ZODIAC trial presented at AHA
